Biomarkers and phenotypes of COPD

Thematic Poster
Chairs: Amal Houssaini (Evry, France), Therese Lapperre (Copenhagen, Denmark)

Comparison of blood eosinophils and plasma periostin in stable and non-stable chronic obstructive pulmonary disease: How we can improve the management of our patients Alizamin Sadigov (Baku, Azerbaijan), Alizamin Sadigov, Konul Abasaliyeva, Sakhvatdin Akhundov, Gunel Sadigova
Alpha1-antytripsin deficiency in portuguese COPD patients Ana Filipa Cruz e Costa (Taveiro, Portugal), Ana Filipa Cruz e Costa, Cidália Rodrigues, Pedro Ulisses Brito
Heterogeneity inside group D COPD patients: About 827 cases Ahmed Ben Saad (5000 Monastir, Tunisia), Ahmed Ben Saad, Saoussen Cheikh Mhammed, Hadhami Mribah, Nesrine Fahem, Samah Joobeur, Naceur Rouatbi, Ali El Kamel
CAT predicts mortality in COPD patients who require LTOT Nikolay Kyuchukov (Belene, Bulgaria), Nikolay Kyuchukov, Nikolay Yanev, Iliya Krachunov, Zlatina Ivanova, Preslava Kyuchukova, Petkana Hristova, Plamen Pavlov, Pavlina Glogovska, Tsanya Popova, Yavor Ivanov
Plasma surfactant protein-D (SPD) concentration and severity of airflow limitation in COPD patients (pts) Kateryna Gashynova (Dniepropetrovsk, Ukraine), Kateryna Gashynova, Tetyana Pertseva
Endothelial dysfunction and systemic inflammation during acute exacerbations of COPD Andrea Vukic Dugac (Zagreb, Croatia), Andrea Vukic Dugac, Alen Ruzic, Ana Hecimovic, Mateja Jankovic-Makek, Gordana Pavlisa, Hrvoje Puretic, Gzim Redjepi, Sanja Popovic-Grle, Miroslav Samarzija, Marko Jakopovic
Blood pressure variability during the 6-minute walk test in patients with chronic obstructive pulmonary disease Arnoldus van Gestel (Winterthur, Switzerland), Arnoldus van Gestel, Andrja Gajic, Florent Baty, Martin Brutsche
The trend of pulmonary function tests over time in COPD patients with different levels of blood eosinophils Paola Rogliani (Rome, Italy), Paola Rogliani, Ermanno Puxeddu, Chiara Ciaprini, Gabriella Pezzuto, Luigino Calzetta, Mario Cazzola
Do inhaled corticosteroids reduce the frequent exacerbator phenotype in COPD - A little help by a multicenter survey Dieter Klopf (Nürnberg, Germany), Dieter Klopf, Johannes Rumpf, Peter Maier-Stocker, Kai Thomas, Christoph Koehl, Claudia Sommer, Peter Berg
GOLD staging and grading for predicting one-year mortality in COPD patients with severe exacerbation Evgeni Mekov (Sofia, Bulgaria), Evgeni Mekov, Yanina Slavova, Adelina Tsakova, Marianka Genova, Dimitar Kostadinov, Delcho Minchev, Dora Marinova, Mihail Boyanov
Resting heart rate and exacerbations in COPD patients Ahmad Izuanuddin Ismail (Selangor, Malaysia), Ahmad Izuanuddin Ismail, Aisya Natasya Musa, Mohd Arif Mohd Zim, Mohd Ariff Fadzil, Norhaya Mohd Razali, Razul Md Nazri Md Kassim, Tengku Saifudin Tengku Ismail
Quality of life at discharge from hospital following acute exacerbation of COPD is much worse even if length of stay is short Lalita Fernandes (Panaji, Goa, India), Lalita Fernandes, Rohit Vadala, Nandani Gulati, Anika Parrikar, Anthony Mesquita
Airway resistance correlates with the frequency of exacerbation in patient with COPD Hitomi Furukawa (Tokyo, Japan), Hitomi Furukawa, Yasunari Kishino, Yasunori Murata, Shin Ohta, Tetsuya Honma, Sojiro Kusumoto, Mayumi Yamamoto, Shintaro Suzuki, Akihiko Tanaka, Takuya Yokoe, Tsukasa Ohnishi, Hironori Sagara
Alpha-1-antitrypsin deficiency in Kazakh subjects with COPD Ardak Zhumagaliyeva (Semey, Kazakhstan), Ardak Zhumagaliyeva, Marina Gorrini, Claus Vogelmeier, Angelo Corsico, Ludmila Karazhanova, Timm Greulich, Annalisa DeSilvestri, Victor Kotke, Valentina Barzon, Michele Zorzetto, Ilaria Ferrarotti
Inflammatory markers (IL-6, suPAR) and arterial stiffness parameters in COPD patients Renáta Marietta Böcskei (Budapest, Hungary), Renáta Marietta Böcskei, Lilla Tamási, Béla Benczúr, András Bikov, György Losonczy, Anikó Bohács
The prognostic value of cardiac and inflammatory biomarkers in acute exacerbations of COPD Louise Goodall (Sydney, Australia), Louise Goodall, Belinda Cochrane, Soo Wei Foo, Phong Nguyen
Serum uric acid levels and uric acid/creatinine ratio in stable COPD patients: Are these parameters efficiently predict risky patients for exacerbation and/or severity of the disease? Nagihan Durmus Kocak (Istanbul, Turkey), Nagihan Durmus Kocak, Gulsah Sasak, Ulku Aka Akturk, Metin Akgun, Sibel Boga, Aysun Sengul, Sinem Gungor, Sibel Arinc
Relation of high resolution computed tomography findings with functional parameters in COPD Gülden Bilgin (Ankara, Turkey), Gülden Bilgin, Pinar Nercis Kosar, Enver Necip Köseoglu
The association between morning symptoms and physical activity in chronic obstructive pulmonary disease: A systematic review Amanda van Buul (Leiden, Netherlands), Amanda van Buul, Marise Kasteleyn, Niels Chavannes, Christian Taube
LATE-BREAKING ABSTRACT: Five items from the CAT questionnaire identify smokers with preserved lung function at higher risk for poor respiratory outcomes: An analysis of the SPIROMICS cohort Carlos Martinez (Ann Arbor, United States of America), Carlos Martinez, Susan Murray, Miguel Quibrera, Prescott Woodruff, Graham Barr, Christopher Cooper, Russell Bowler, Eugene Bleecker, Alejandro Comellas, Stephanie Christenson, David Couper, Jeffrey Curtis, Natalia Gouskova, Gerald Criner, Nadia Hansel, Eric Hoffman, Mark Dransfield, Jerry Krishnan, Nancy Leidy, Richard Kanner, Eric Kleerup, Stephen Lazarus, Fernando Martinez, Wanda O’Neal, Robert Paine, Stephen Rennard, Donald Tashkin, Paul Jones, MeiLan Han